Intrahepatic micrometastases around liver metastases from gastric cancer

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 16, Issue 4, 2009, Pages 493-501

  Nomura, Takashi ^a   Kamio, Yukinori ^a   Takasu, Naoki ^a   Moriya, Toshiyuki ^a   Takeshita, Akiko ^a   Mizutani, Masaomi ^a   Hachiya, Osamu ^a   Hirai, Ichiro ^a   Kimura, Wataru ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

E cadherin; Gastric cancer; Intrahepatic micrometastases; Liver metastases; MMP 7

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN; DOXIFLURIDINE; DOXORUBICIN; FLUOROURACIL; MATRILYSIN; METHOTREXATE; MITOMYCIN C; UFT; UVOMORULIN;

AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LIVER RESECTION; LIVER SINUSOID; LIVER TUMOR; LYMPH VESSEL; MALE; MICROMETASTASIS; PROTEIN EXPRESSION; STOMACH CANCER; SURVIVAL TIME;

ADULT; AGED; CADHERINS; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; FEMALE; HEPATECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PORTAL VEIN; STOMACH NEOPLASMS;

EID: 67650542057     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-009-0081-y     Document Type: Article

References (29)

1. Okano K, Maeba T, Ishimura K, Karasawa Y, Goda F, Wakabayashi H, et al. Hepatic resection for metastatic tumors from gastric cancer. Ann Surg. 2002;235:86-91.
2. Sakamoto Y, Ohyama S, Yamamoto J, Yamada K, Seki M, Ohta K, et al. Surgical resection of liver metastases of gastric cancer: An analysis of a 17-year experience with 22 patients. Surgery. 2003;133:507-11.
3. Miyazaki M, Itoh H, Nakagawa K, Ambiru S, Shimizu H, Togawa A, et al. Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol. 1997;92:490-3.
4. Shi M, Zhang CQ, Zhang YQ, Liang XM, Li JQ. Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg. 2004;28:376-81.
5. Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, et al. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: Minimum surgical margins for successful resection. Arch Surg. 2002;137:833-40.
6. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 2nd English ed. Gastric Cancer 1998;1:10-24.
7. Sugano H, Nakamura K, Kato Y. Pathological studies of human gastric cancer. Acta Pathol Jpn. 1982;32(Suppl 2):329-47.
8. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89:500-7.
9. Nakashima O, Kojiro M. Recurrence of hepatocellular carcinoma: multicentric occurrence or intrahepatic metastasis? A viewpoint in terms of pathology. J Hepatobiliary Pancreat Surg. 2001;8:404-9.
10. Kato T, Yasui K, Hirai T, Kanemitsu Y, Mori T, Sugihara K, et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: Analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum. 2003;46:S22-31.
11. Belli G, D'Agostino A, Ciciliano F, Fantini C, Russolillo N, Belli A. Liver resection for hepatic metastases: 15 years of experience. J Hepatobiliary Pancreat Surg. 2002;9:607-13.
12. Nakamura S, Suzuki S, Konno H. Resection of hepatic metastases of colorectal carcinoma: 20 years' experience. J Hepatobiliary Pancreat Surg. 1999;6:16-22.
13. Nanko M, Shimada H, Yamaoka H, Tanaka K, Masui H, Matsuo K, et al. Micrometastatic colorectal cancer lesions in the liver. Surg Today. 1998;28:707-13.
14. Yokoyama N, Shirai Y, Ajioka Y, Nagakura S, Suda T, Hatakeyama K. Immunohistochemically detected hepatic micrometastases predict a high risk of intrahepatic recurrence after resection of colorectal carcinoma liver metastases. Cancer. 2002;94:1642-7.
15. Imamura H, Matsuyama Y, Shimada R, Kubota M, Nakayama A, Kobayashi A, et al. A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol. 2001;96:3178-84.
16. Isono T, Miyazaki M, Udagawa I, Koshikawa H, Iinuma K, Itoh H, et al. The clinicopathological study of intrahepatic micrometastases in hepatic metastatic carcinioma: Comparison between hepatic metastasis of gastric cancer and of colorectal cancer. J Jpn Soc Cancer Ther. 1992;27:893-9.
17. Ambiru S, Miyazaki M, Ito H, Nakagawa K, Shimizu H, Yoshidome H, et al. Benefits and limits of hepatic resection for gastric metastases. Am J Surg. 2001;181:279-83.
18. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res. 1993;53:1690-5.
19. Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W, et al. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer. 1996;69:184-9.
20. Lee KH, Shin SJ, Kim KO, Kim MK, Hyun MS, Kim TN, et al. Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma. Oncol Rep. 2006;16:823-30.
21. Zheng HC, Sun JM, Li XH, Yang XF, Zhang YC, Xin Y. Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma. Pathol Int. 2003;53:659-66.
22. Ougolkov A, Yamashita K, Bilim V, Takahashi Y, Mai M, Minamoto T. Abnormal expression of E-cadherin, beta-catenin, and c-erbB-2 in advanced gastric cancer: Its association with liver metastasis. Int J Colorectal Dis. 2003;18:160-6.
23. Yonemura Y, Endou Y, Kimura K, Fushida S, Bandou E, Taniguchi K, et al. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res. 2000;6:4234-42.
24. Yonemura Y, Endou Y, Fujita H, Fushida S, Bandou E, Taniguchi K, et al. Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer. Gastric Cancer. 2000;3:63-70.
25. Inayoshi J, Ichida T, Sugitani S, Tsuboi Y, Genda T, Honma N, et al. Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment. J Gastroenterol Hepatol. 2003;18:673-7.
26. Gao ZH, Tretiakova MS, Liu WH, Gong C, Farris PD, Hart J. Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma. Mod Pathol. 2006;19:533-40.
27. Ishii Y, Nakasato Y, Kobayashi S, Yamazaki Y, Aoki T. A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma. J Exp Clin Cancer Res. 2003;22:461-70.
28. Nanashinma A, Yamaguchi H, Sawai T, Yasutake T, Tsuiji T, Jibiki E. Expression of adhesion molecules in hepatic metastases of colorectal carcinoma: Relationships to primary tumors and prognosis after hepatic resection. J Gastroenterol Hepatol. 1999;14:1004-9.
29. Zeng ZS, Shu WP, Cohen AM, Guillem JG. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: Evidence for involvement of MMP-7 activation in human cancer metastases. Clin Cancer Res. 2002;8:144-8.